PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
GoInVivo™ Purified anti-human CD152 (CTLA-4), 1 g
GoInVivo™ Purified anti-human CD152 (CTLA-4), 100 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 25 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 5 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 50 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 500 mg
GoInVivo™ Purified anti-human CD274 (B7-H1, PD-L1), 1 g
GoInVivo™ Purified anti-human CD274 (B7-H1, PD-L1), 100 mg
GoInVivo™ Purified anti-human CD274 (B7-H1, PD-L1), 25 mg
GoInVivo™ Purified anti-human CD274 (B7-H1, PD-L1), 5 mg
GoInVivo™ Purified anti-human CD274 (B7-H1, PD-L1), 50 mg
GoInVivo™ Purified anti-human CD274 (B7-H1, PD-L1), 500 mg
GoInVivo™ Purified anti-human CD279 (PD-1), 1 g
GoInVivo™ Purified anti-human CD279 (PD-1), 100 mg
GoInVivo™ Purified anti-human CD279 (PD-1), 25 mg
GoInVivo™ Purified anti-human CD279 (PD-1), 5 mg